Verve Therapeutics Inc. (VERV)
NASDAQ: VERV
· Real-Time Price · USD
11.13
0.03 (0.27%)
At close: Jul 24, 2025, 3:59 PM
Verve Therapeutics Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 32.98M | 13.08M | 6.87M | 6.69M | 5.7M | 5.14M | 3.12M | 2.09M | 1.4M | 1.01M | 929K | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit | 32.98M | 13.08M | 6.87M | 6.69M | 5.7M | 5.14M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Income | -36.64M | -56.07M | -56.91M | -58.84M | -56.84M | -53.95M | -52.33M | -58.58M | -58.26M | -47.71M | -43.86M | -42.19M | -31.93M | -32.54M | -23.5M | -16.96M | -14.06M |
Interest Income | 5.46M | n/a | 6.89M | 7.43M | 8.14M | n/a | 5.84M | 5.44M | 5.55M | n/a | 1.98M | 308K | 82K | n/a | 53K | 5K | 20K |
Pretax Income | -30.95M | -49.96M | -50.03M | -49.74M | -48.63M | -48.32M | -45.69M | -53.81M | -51.98M | -41.03M | -45.19M | -40.95M | -30.17M | -31.34M | -22.75M | -52.97M | -13.26M |
Net Income | -31.03M | -50.03M | -50.13M | -49.8M | -48.74M | -48.35M | -45.76M | -53.98M | -45.69M | -41.09M | -46.52M | -39.7M | -28.41M | -31.34M | -22.75M | -52.97M | -13.26M |
Selling & General & Admin | 15.15M | 14.1M | 13.84M | 14.55M | 14.16M | 12.28M | 11.69M | 13.42M | 12.55M | 11.44M | 9.59M | 9.07M | 7.43M | 6.6M | 6.01M | 3.54M | 2.72M |
Research & Development | 54.46M | 55.05M | 49.94M | 50.98M | 48.38M | 46.81M | 43.77M | 47.26M | 47.11M | 37.28M | 35.2M | 33.13M | 24.49M | 25.94M | 17.5M | 13.42M | 11.35M |
Other Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 69.61M | 69.15M | 63.77M | 65.53M | 62.54M | 59.09M | 55.45M | 60.68M | 59.66M | 48.72M | 44.79M | 42.19M | 31.93M | 32.54M | 23.5M | 16.96M | 14.06M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 69.61M | 69.15M | 63.77M | 65.53M | 62.54M | 59.09M | 55.45M | 60.68M | 59.66M | 48.72M | 44.79M | 42.19M | 31.93M | 32.54M | 23.5M | 16.96M | 14.06M |
Income Tax Expense | 79K | 73K | 104K | 66K | 106K | 32K | 67K | 176K | -6.28M | 53K | 1.33M | -1.25M | -1.76M | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 88.8M | 86.87M | 84.63M | 84.23M | 83.13M | 69.67M | 63.21M | 61.95M | 61.79M | 61.46M | 57.21M | 48.67M | 48.57M | 48.03M | 47.99M | 47.95M | 43.82M |
Shares Outstanding (Diluted) | 88.8M | 86.87M | 84.63M | 84.23M | 83.13M | 69.67M | 63.21M | 61.95M | 61.79M | 61.46M | 57.21M | 48.67M | 48.57M | 48.03M | 47.99M | 47.95M | 43.82M |
EPS (Basic) | -0.35 | -0.58 | -0.59 | -0.59 | -0.59 | -0.69 | -0.72 | -0.87 | -0.74 | -0.67 | -0.81 | -0.82 | -0.58 | -0.65 | -0.47 | -1.1 | -0.3 |
EPS (Diluted) | -0.35 | -0.58 | -0.59 | -0.59 | -0.59 | -0.69 | -0.72 | -0.87 | -0.74 | -0.67 | -0.81 | -0.82 | -0.58 | -0.65 | -0.47 | -1.1 | -0.3 |
EBITDA | -34.92M | -54.37M | -55.16M | -57.17M | -55.21M | -52.43M | -50.86M | -57.25M | -57.13M | -46.78M | -43.14M | -41.54M | -31.41M | -32.07M | -23.09M | -16.61M | -13.77M |
EBIT | -36.64M | -56.07M | -56.91M | -58.84M | -56.84M | -53.95M | -52.33M | -58.58M | -58.26M | -47.71M | -43.86M | -42.19M | -31.93M | -32.54M | -23.5M | -16.96M | -14.06M |
Depreciation & Amortization | 1.72M | 1.7M | 1.75M | 1.67M | 1.63M | 1.52M | 3.2M | 3.03M | 2.76M | 2.55M | 2M | 1.15M | 1.01M | 969K | 1.76M | 357K | 294K |